CCA
TMO icon

Criterion Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Criterion Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$656K Hold
1,186
– – 0.41% 49
2024
Q3 		$656K Hold
1,186
– – 0.41% 49
2024
Q2 		$656K Buy
1,186
+2
+0.2% +$1.15K 0.41% 49
2024
Q1 		$688K Buy
1,184
+330
+39% +$185K 0.46% 47
2023
Q4 		$453K Buy
+854
New +$413K 0.33% 56

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Criterion Capital Advisors's TMO Position: Q4 2024 in Review

Criterion Capital Advisors held its Thermo Fisher Scientific (TMO) position steady in Q4 2024 at 1,186 shares worth $656K. The position accounts for 0.41% of the portfolio, ranked #49.

Criterion Capital Advisors first reported a position in TMO in Q4 2023 and has held it in 5 quarters since. The position peaked at $688K in Q1 2024. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Criterion Capital Advisors held 1,186 shares of Thermo Fisher Scientific worth $656K as of Q4 2024.
  • Criterion Capital Advisors left its Thermo Fisher Scientific share count unchanged in Q4 2024.
  • Thermo Fisher Scientific made up 0.41% of Criterion Capital Advisors's portfolio in Q4 2024, its #49 holding.
  • Criterion Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 5 quarters since.
  • Criterion Capital Advisors's Thermo Fisher Scientific position peaked at $688K in Q1 2024.
  • 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Criterion Capital Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.